Skip to main content
. 2023 Nov 7;13(22):3395. doi: 10.3390/diagnostics13223395

Table 3.

Nominal dose statistics for manual flash (MF) and robust optimized (RO) plans.

Parameter MF Plan RO Plan p-Value
Target volume CTV V95% (%) 99.61 ± 0.07 97.67 ± 0.21 <0.001 *
CTV V100% (%) 97.45 ± 0.25 92.51 ± 0.43 <0.001 *
CTV V107% (%) 5.35 ± 0.70 4.08 ± 0.33 0.105
CTV D98% (cGy) 4995.00 ± 6.41 4466.62 ± 101.17 <0.001 *
CTV D2% (cGy) 5382.38 ± 5.83 5377.06 ± 4.39 0.484
CTV Dmax (cGy) 5509.03 ± 10.64 5523.94 ± 10.79 0.326
Organs at risk Ipsilateral lung V500cGy (%) 60.64 ± 0.56 60.97 ± 1.01 0.809
Ipsilateral lung V1000cGy (%) 44.44 ± 0.44 44.50 ± 0.44 0.921
Ipsilateral lung V2000cGy (%) 30.02 ± 0.42 29.78 ± 0.71 0.768
Contralateral lung V500cGy (%) 9.58 ± 0.33 8.08 ± 0.42 0.002 *
Heart Dmean (cGy) 370.00 ± 12.58 345.76 ± 10.85 0.114

Figures are expressed in mean ± standard deviation. CTV, clinical target volume; D2%/98%, dose received by 2%/98% of structure, respectively; Dmax, maximum dose received by structure; Dmean, average dose received by structure; V95%/100%/107%, volume of structure receiving more than 95%/100%/107% of prescribed dose, respectively; V500/1000/2000cGy, volume of structure receiving 500/1000/2000 cGy dose, respectively. * denotes statistically significant difference.